Western [spco]
Patients [podg]
Japan [geoa]
Atherosclerosis [dsyn]
society [orgt]
Goals [inpr]
rosuvastatin [orch, phsu]
therapy [ftcn]
atorvastatin [orch, phsu]
Pravastatin [orch, phsu]
Simvastatin [orch, phsu]
therapy [ftcn]
Western [spco]
Trial [resa]
Suggest [idcn]
rosuvastatin [orch, phsu]
effective [qlco]
atorvastatin [orch, phsu]
Simvastatin [orch, phsu]
Pravastatin [orch, phsu]
Patients [podg]
European [popg]
Lipid [lipd]
lowering [spco]
Guidelines [inpr]
Purpose [ftcn]
Efficacy [qlco]
rosuvastatin [orch, phsu]
Reducing [qlco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Levels [qlco]
Recommended [idcn]
Japan [geoa]
Atherosclerosis [dsyn]
society [orgt]
Methods [inpr]
Post [tmco]
randomized controlled trials [inpr, resa]
DOUBLE BLIND [resa]
Active [ftcn]
Conduct [inbe]
Evaluate [ftcn]
Relative [famg]
Efficacy [qlco]
rosuvastatin [orch, phsu]
Comparator [mnob]
Statins [orch, phsu]
Help [socb]
Patients [podg]
Goals [inpr]
Established [qlco]
Japan [geoa]
Atherosclerosis [dsyn]
society [orgt]
Trial [resa]
Design [acty]
Pooling [ftcn]
Conduct [inbe]
effects [qlco]
rosuvastatin [orch, phsu]
atorvastatin [orch, phsu]
Pravastatin [orch, phsu]
Reducing [qlco]
Lipid level [lbtr]
Help [socb]
Patients [podg]
Goals [inpr]
Established [qlco]
national [inpr]
Cholesterol [bacs, strd]
educational program [edac]
Trial [resa]
Conduct [inbe]
objectives [inpr]
Patients [podg]
Heterozygous [orga]
familial [famg]
Patients [podg]
Trial [resa]
Pooled [cnce]
rosuvastatin [orch, phsu]
mg% [qnco]
N NOS [aapp, imft]
mg% [qnco]
N NOS [aapp, imft]
atorvastatin 10 MG [clnd]
N NOS [aapp, imft]
rosuvastatin [orch, phsu]
mg% [qnco]
N NOS [aapp, imft]
N NOS [aapp, imft]
Simvastatin [orch, phsu]
N NOS [aapp, imft]
Pravastatin [orch, phsu]
N NOS [aapp, imft]
atorvastatin [orch, phsu]
Comparator [mnob]
Japan [geoa]
Atherosclerosis [dsyn]
society [orgt]
Defined [cnce]
Goals [inpr]
Reach [orgf]
rosuvastatin [orch, phsu]
mg% [qnco]
Group [idcn]
rosuvastatin [orch, phsu]
mg% [qnco]
Group [idcn]
atorvastatin 10 MG [clnd]
Group [idcn]
P NOS [aapp, imft]
rosuvastatin [orch, phsu]
Group [idcn]
atorvastatin [orch, phsu]
weeks [tmco]
Trial [resa]
Pravastatin [orch, phsu]
Comparator [mnob]
Japan [geoa]
Atherosclerosis [dsyn]
society [orgt]
LDLC [gngm]
Goals [inpr]
Reach [orgf]
rosuvastatin [orch, phsu]
mg% [qnco]
Group [idcn]
rosuvastatin [orch, phsu]
mg% [qnco]
Group [idcn]
Pravastatin [orch, phsu]
mg% [qnco]
Group [idcn]
Simvastatin 20 MG [clnd]
Group [idcn]
P NOS [aapp, imft]
rosuvastatin [orch, phsu]
Group [idcn]
Pravastatin [orch, phsu]
Trial [resa]
Patients [podg]
N NOS [aapp, imft]
rosuvastatin [orch, phsu]
N NOS [aapp, imft]
atorvastatin [orch, phsu]
Patients [podg]
treated [topp]
rosuvastatin [orch, phsu]
mg% [qnco]
Japan [geoa]
Atherosclerosis [dsyn]
society [orgt]
Goals [inpr]
Compared [acty]
Patients [podg]
treated [topp]
atorvastatin 20 MG [clnd]
P NOS [aapp, imft]
Conclusions [idcn]
rosuvastatin [orch, phsu]
superiority [socb]
atorvastatin [orch, phsu]
Pravastatin [orch, phsu]
Reducing [qlco]
Enabling [menp]
Patients [podg]
Reach [orgf]
Goals [inpr]
Established [qlco]
Japan [geoa]
Atherosclerosis [dsyn]
society [orgt]
